Metabolic response of blood vessels to TNFα

  1. Abidemi Junaid
  2. Johannes Schoeman
  3. Wei Yang
  4. Wendy Stam
  5. Alireza Mashaghi
  6. Anton Jan van Zonneveld
  7. Thomas Hankemeier  Is a corresponding author
  1. Leiden University, Netherlands
  2. Leiden University Medical Center, Netherlands

Abstract

TNFa signaling in the vascular endothelium elicits multiple inflammatory responses that drive vascular destabilization and leakage. Bioactive lipids are main drivers of these processes. In vitro mechanistic studies of bioactive lipids have been largely based on two-dimensional endothelial cell cultures that, due to lack of laminar flow and the growth of the cells on non-compliant stiff substrates, often display a pro-inflammatory phenotype. This complicates the assessment of inflammatory processes. Three-dimensional microvessels-on-a-chip models provide a unique opportunity to generate endothelial microvessels in a more physiological environment. Using an optimized targeted liquid chromatography-tandem mass spectrometry measurements of a panel of pro- and anti-inflammatory bioactive lipids, we measure the profile changes upon administration of TNFa. We demonstrate that bioactive lipid profiles can be readily detected from three-dimensional microvessels-on-a-chip and display a more dynamic, less inflammatory response to TNFa, that resembles more the human situation, compared to classical two-dimensional endothelial cell cultures.

Data availability

The data used to generate the figures and tables can be found in the Source Data File.

Article and author information

Author details

  1. Abidemi Junaid

    Systems Pharmacology Cluster, Analytical Biosciences, LACDR, Leiden University, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  2. Johannes Schoeman

    Systems Pharmacology Cluster, Analytical Biosciences, LACDR, Leiden University, Leiden, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0905-2467
  3. Wei Yang

    Systems Pharmacology Cluster, Analytical Biosciences, LACDR, Leiden University, Leiden, Netherlands
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3394-7570
  4. Wendy Stam

    Department of Internal Medicine (Nephrology), Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  5. Alireza Mashaghi

    Systems Pharmacology Cluster, Medical Systems Biophysics and Bioengineering, LACDR, Leiden University, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  6. Anton Jan van Zonneveld

    Department of Internal Medicine (Nephrology), Leiden University Medical Center, Leiden, Netherlands
    Competing interests
    No competing interests declared.
  7. Thomas Hankemeier

    Systems Pharmacology Cluster, Analytical Biosciences, LACDR, Leiden University, Leiden, Netherlands
    For correspondence
    hankemeier@lacdr.leidenuniv.nl
    Competing interests
    Thomas Hankemeier, TH is co-founder of MIMETAS and has some shares in MIMETAS..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7871-2073

Funding

Hartstichting (RECONNECT CVON Groot)

  • Abidemi Junaid
  • Anton Jan van Zonneveld
  • Thomas Hankemeier

ZonMw (114022501)

  • Abidemi Junaid
  • Anton Jan van Zonneveld
  • Thomas Hankemeier

Nederlandse Organisatie voor Wetenschappelijk Onderzoek (16249)

  • Alireza Mashaghi
  • Thomas Hankemeier

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Junaid et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,404
    views
  • 347
    downloads
  • 16
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Abidemi Junaid
  2. Johannes Schoeman
  3. Wei Yang
  4. Wendy Stam
  5. Alireza Mashaghi
  6. Anton Jan van Zonneveld
  7. Thomas Hankemeier
(2020)
Metabolic response of blood vessels to TNFα
eLife 9:e54754.
https://doi.org/10.7554/eLife.54754

Share this article

https://doi.org/10.7554/eLife.54754

Further reading

    1. Medicine
    Teruhiko Yoshida, Khun Zaw Latt ... Jeffrey B Kopp
    Research Article

    HIV disease remains prevalent in the USA and chronic kidney disease remains a major cause of morbidity in HIV-1-positive patients. Host double-stranded RNA (dsRNA)-activated protein kinase (PKR) is a sensor for viral dsRNA, including HIV-1. We show that PKR inhibition by compound C16 ameliorates the HIV-associated nephropathy (HIVAN) kidney phenotype in the Tg26 transgenic mouse model, with reversal of mitochondrial dysfunction. Combined analysis of single-nucleus RNA-seq and bulk RNA-seq data revealed that oxidative phosphorylation was one of the most downregulated pathways and identified signal transducer and activator of transcription (STAT3) as a potential mediating factor. We identified in Tg26 mice a novel proximal tubular cell cluster enriched in mitochondrial transcripts. Podocytes showed high levels of HIV-1 gene expression and dysregulation of cytoskeleton-related genes, and these cells dedifferentiated. In injured proximal tubules, cell-cell interaction analysis indicated activation of the pro-fibrogenic PKR-STAT3-platelet-derived growth factor (PDGF)-D pathway. These findings suggest that PKR inhibition and mitochondrial rescue are potential novel therapeutic approaches for HIVAN.

    1. Cancer Biology
    2. Medicine
    Anastasia D Komarova, Snezhana D Sinyushkina ... Marina V Shirmanova
    Research Article

    Heterogeneity of tumor metabolism is an important, but still poorly understood aspect of tumor biology. Present work is focused on the visualization and quantification of cellular metabolic heterogeneity of colorectal cancer using fluorescence lifetime imaging (FLIM) of redox cofactor NAD(P)H. FLIM-microscopy of NAD(P)H was performed in vitro in four cancer cell lines (HT29, HCT116, CaCo2 and CT26), in vivo in the four types of colorectal tumors in mice and ex vivo in patients’ tumor samples. The dispersion and bimodality of the decay parameters were evaluated to quantify the intercellular metabolic heterogeneity. Our results demonstrate that patients’ colorectal tumors have significantly higher heterogeneity of energy metabolism compared with cultured cells and tumor xenografts, which was displayed as a wider and frequently bimodal distribution of a contribution of a free (glycolytic) fraction of NAD(P)H within a sample. Among patients’ tumors, the dispersion was larger in the high-grade and early stage ones, without, however, any association with bimodality. These results indicate that cell-level metabolic heterogeneity assessed from NAD(P)H FLIM has a potential to become a clinical prognostic factor.